Skip to main content

Advertisement

Log in

Contact Dermatitis and Patch Tests in Pregnancy

  • Pregnancy Dermatoses and Fetal Exposure (A Ingber and Y Ramot, Section Editors)
  • Published:
Current Dermatology Reports Aims and scope Submit manuscript

Abstract

Contact dermatitis (CD) is a common itchy inflammatory skin disease. It is the most common skin disease in industrialized societies. In a recent study the incidence rates of CD was found to be 13.4 % and the point prevalence was found as 20.1 % (Mortz, Bindslev-Jensen and Andersen Br, J Dermatol 2013;168(2):318–25). There are two main types of CD: irritant contact dermatitis (ICD) and allergic contact dermatitis (ACD). Most cases are ICD (80 %). ICD is a non-immune non specific reaction caused by direct injury to the skin by strong irritants like: strong acids and alkalis. ACD is an immune mediated delayed type hypersensitivity reaction induced by many materials (allergens) like: metals, preservatives, perfumes, rubber, resins, dyes and many more. This type of CD appears only in patients that previously were sensitized to these materials (Ale and Maibacht, Expert Rev Clin Immunol 2010;6(2):291–310). Patch tests are used to identify the culprit allergens. In this article we will discuss the issues of contact dermatitis and patch testing in pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Akiba H, Kehren J, Ducluzeau MT, Krasteva M, Horand F, Kaiserlian D, et al. Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis. J Immunol. 2002;168(6):3079.

    Article  CAS  PubMed  Google Scholar 

  2. Ale IS, Maibacht HA. Diagnostic approach in allergic and irritant contact dermatitis. Expert Rev Clin Immunol. 2010;6(2):291–310.

    Article  PubMed  Google Scholar 

  3. Baadsgaad O, Wang T. Immune regulation in allergic and irritant skin reactions. Int J Dermatol. 1991;30:161–72.

    Article  Google Scholar 

  4. Kaplan DH, Kissenpfennig A, Clausen BE. Insights into Langerhans cell function from Langerhans cell ablation models. Eur J Immunol. 2008;38(9):2369.

    Article  CAS  PubMed  Google Scholar 

  5. Mortz CG, Bindslev-Jensen C, Andersen KE. Prevalence, incidence rates and persistence of contact allergy and allergic contact dermatitis in the odense adolescence cohort study. Br J Dermatol. 2013;168(2):318–25.

    Article  CAS  PubMed  Google Scholar 

  6. Honda T, Miyachi Y, Kabashima K. Regulatory T cells in cutaneous immune responses. J Dermatol Sci. 2011;63(2):75. An excellent review on new developments regarding the inhibition of allergic contact dermatitis.

  7. Martin SF, Esser PR, Weber FC, Jakob T, Freudenberg MA, Schmidt M, et al. Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy. 2011;66(9):1152.

    Article  CAS  PubMed  Google Scholar 

  8. Asadulla K, Sabat R, Wiese A, et al. Interleukin-10 in cutaneous disorders: implication for its pathophysiological importance and therapeutic use. Arch Dermatol Res. 1999;291:628–36.

    Article  Google Scholar 

  9. Kondo S, McKenzie RC, Sauder DN. Interleukin-10 inhibits the elicitation phase of allergic contact hypersensitivity. J Invest Dermatol. 1999;103:811–4.

    Article  Google Scholar 

  10. Kotenko SV, Krause CD, Izotova LS, et al. Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J. 1997;16:5894–903.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Ambros-Rudolph CM, Müllegger RR, Vaughan-Jones SA, Kerl H, Black MM. The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol. 2006;54(3):395–404.

    Article  PubMed  Google Scholar 

  12. Wagner G, Porschel W. Klinisch analytische studie zum neurodermatitisproblem. Dermatologica. 1962;125:1–32.

    Article  CAS  PubMed  Google Scholar 

  13. Seeberg G. Hudens reactivitet for ivattmedel I deras egenskap aatr primart hundretande amnem. Svenska Lakardingen. 1955;52:3081.

    CAS  Google Scholar 

  14. Grup G. Hand eczema and other dermatoses in south Sweden. Acta Derm Venereo. 1969;49(Suppl.):69.

  15. Rysted I. Factors influencing the occurrence of hand eczema in adults with a history of atopic dermatitis in childhood. Contact Dermatitis. 1985;12:247–54.

    Article  Google Scholar 

  16. Patil S, Maibach HI. Effect of age and sex on the elicitation of irritant contact dermatitis. Contact Dermatitis. 1994;30:257–64.

    Article  CAS  PubMed  Google Scholar 

  17. Ostrowski A, Nordmeyer D, Boreham A, Brodwolf R, Mundhenk L, Fluhr JW, Lademann J, Graf C, Rühl E, Alexiev U, Gruber AD. Skin barrier disruptions in tape stripped and allergic dermatitis models have no effect on dermal penetration and systemic distribution of AHAPS-functionalized silica nanoparticles. Nanomedicine. 2014;22:S1549-9634. An important study that demonstrated there is no dermal penetration and systemic distribution of nanoparticels, even in disrupted skin. From this, one may conclude that allergens in patch tests applied on intake skin are not penetrated into blood circulation.

Download references

Conflict of Interest

A Ingber declares no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arieh Ingber.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ingber, A. Contact Dermatitis and Patch Tests in Pregnancy. Curr Derm Rep 3, 141–143 (2014). https://doi.org/10.1007/s13671-014-0081-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13671-014-0081-2

Keywords

Navigation